Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 22

1.

EOMES interacts with RUNX3 and BRG1 to promote innate memory cell formation through epigenetic reprogramming.

Istaces N, Splittgerber M, Lima Silva V, Nguyen M, Thomas S, Le A, Achouri Y, Calonne E, Defrance M, Fuks F, Goriely S, Azouz A.

Nat Commun. 2019 Jul 24;10(1):3306. doi: 10.1038/s41467-019-11233-6.

2.

TET2-Dependent Hydroxymethylome Plasticity Reduces Melanoma Initiation and Progression.

Bonvin E, Radaelli E, Bizet M, Luciani F, Calonne E, Putmans P, Nittner D, Singh NK, Santagostino SF, Petit V, Larue L, Marine JC, Fuks F.

Cancer Res. 2019 Feb 1;79(3):482-494. doi: 10.1158/0008-5472.CAN-18-1214. Epub 2018 Dec 11.

PMID:
30538121
3.

Comprehensive identification of long noncoding RNAs in colorectal cancer.

James de Bony E, Bizet M, Van Grembergen O, Hassabi B, Calonne E, Putmans P, Bontempi G, Fuks F.

Oncotarget. 2018 Jun 12;9(45):27605-27629. doi: 10.18632/oncotarget.25218. eCollection 2018 Jun 12.

4.

Immunity drives TET1 regulation in cancer through NF-κB.

Collignon E, Canale A, Al Wardi C, Bizet M, Calonne E, Dedeurwaerder S, Garaud S, Naveaux C, Barham W, Wilson A, Bouchat S, Hubert P, Van Lint C, Yull F, Sotiriou C, Willard-Gallo K, Noel A, Fuks F.

Sci Adv. 2018 Jun 20;4(6):eaap7309. doi: 10.1126/sciadv.aap7309. eCollection 2018 Jun.

5.

The transcription factors Runx3 and ThPOK cross-regulate acquisition of cytotoxic function by human Th1 lymphocytes.

Serroukh Y, Gu-Trantien C, Hooshiar Kashani B, Defrance M, Vu Manh TP, Azouz A, Detavernier A, Hoyois A, Das J, Bizet M, Pollet E, Tabbuso T, Calonne E, van Gisbergen K, Dalod M, Fuks F, Goriely S, Marchant A.

Elife. 2018 Feb 28;7. pii: e30496. doi: 10.7554/eLife.30496.

6.

DNA methylation-based immune response signature improves patient diagnosis in multiple cancers.

Jeschke J, Bizet M, Desmedt C, Calonne E, Dedeurwaerder S, Garaud S, Koch A, Larsimont D, Salgado R, Van den Eynden G, Willard Gallo K, Bontempi G, Defrance M, Sotiriou C, Fuks F.

J Clin Invest. 2017 Aug 1;127(8):3090-3102. doi: 10.1172/JCI91095. Epub 2017 Jul 17.

7.

Portraying breast cancers with long noncoding RNAs.

Van Grembergen O, Bizet M, de Bony EJ, Calonne E, Putmans P, Brohée S, Olsen C, Guo M, Bontempi G, Sotiriou C, Defrance M, Fuks F.

Sci Adv. 2016 Sep 2;2(9):e1600220. doi: 10.1126/sciadv.1600220. eCollection 2016 Sep.

8.

The interplay between the lysine demethylase KDM1A and DNA methyltransferases in cancer cells is cell cycle dependent.

Brenner C, Luciani J, Bizet M, Ndlovu M, Josseaux E, Dedeurwaerder S, Calonne E, Putmans P, Cartron PF, Defrance M, Fuks F, Deplus R.

Oncotarget. 2016 Sep 13;7(37):58939-58952. doi: 10.18632/oncotarget.10624.

9.

RNA biochemistry. Transcriptome-wide distribution and function of RNA hydroxymethylcytosine.

Delatte B, Wang F, Ngoc LV, Collignon E, Bonvin E, Deplus R, Calonne E, Hassabi B, Putmans P, Awe S, Wetzel C, Kreher J, Soin R, Creppe C, Limbach PA, Gueydan C, Kruys V, Brehm A, Minakhina S, Defrance M, Steward R, Fuks F.

Science. 2016 Jan 15;351(6270):282-5. doi: 10.1126/science.aac5253.

10.

MicroRNAs regulate KDM5 histone demethylases in breast cancer cells.

Denis H, Van Grembergen O, Delatte B, Dedeurwaerder S, Putmans P, Calonne E, Rothé F, Sotiriou C, Fuks F, Deplus R.

Mol Biosyst. 2016 Feb;12(2):404-13. doi: 10.1039/c5mb00513b.

PMID:
26621457
11.

Genome-wide hydroxymethylcytosine pattern changes in response to oxidative stress.

Delatte B, Jeschke J, Defrance M, Bachman M, Creppe C, Calonne E, Bizet M, Deplus R, Marroquí L, Libin M, Ravichandran M, Mascart F, Eizirik DL, Murrell A, Jurkowski TP, Fuks F.

Sci Rep. 2015 Aug 4;5:12714. doi: 10.1038/srep12714.

12.

Regulation of DNA methylation patterns by CK2-mediated phosphorylation of Dnmt3a.

Deplus R, Blanchon L, Rajavelu A, Boukaba A, Defrance M, Luciani J, Rothé F, Dedeurwaerder S, Denis H, Brinkman AB, Simmer F, Müller F, Bertin B, Berdasco M, Putmans P, Calonne E, Litchfield DW, de Launoit Y, Jurkowski TP, Stunnenberg HG, Bock C, Sotiriou C, Fraga MF, Esteller M, Jeltsch A, Fuks F.

Cell Rep. 2014 Aug 7;8(3):743-53. doi: 10.1016/j.celrep.2014.06.048. Epub 2014 Jul 24.

13.

Citrullination of DNMT3A by PADI4 regulates its stability and controls DNA methylation.

Deplus R, Denis H, Putmans P, Calonne E, Fourrez M, Yamamoto K, Suzuki A, Fuks F.

Nucleic Acids Res. 2014 Jul;42(13):8285-96. doi: 10.1093/nar/gku522. Epub 2014 Jun 23.

14.

Dietary flavanols modulate the transcription of genes associated with cardiovascular pathology without changes in their DNA methylation state.

Milenkovic D, Vanden Berghe W, Boby C, Leroux C, Declerck K, Szarc vel Szic K, Heyninck K, Laukens K, Bizet M, Defrance M, Dedeurwaerder S, Calonne E, Fuks F, Haegeman G, Haenen GR, Bast A, Weseler AR.

PLoS One. 2014 Apr 24;9(4):e95527. doi: 10.1371/journal.pone.0095527. eCollection 2014.

15.

A comprehensive overview of Infinium HumanMethylation450 data processing.

Dedeurwaerder S, Defrance M, Bizet M, Calonne E, Bontempi G, Fuks F.

Brief Bioinform. 2014 Nov;15(6):929-41. doi: 10.1093/bib/bbt054. Epub 2013 Aug 29. Review.

16.

TET2 and TET3 regulate GlcNAcylation and H3K4 methylation through OGT and SET1/COMPASS.

Deplus R, Delatte B, Schwinn MK, Defrance M, Méndez J, Murphy N, Dawson MA, Volkmar M, Putmans P, Calonne E, Shih AH, Levine RL, Bernard O, Mercher T, Solary E, Urh M, Daniels DL, Fuks F.

EMBO J. 2013 Mar 6;32(5):645-55. doi: 10.1038/emboj.2012.357. Epub 2013 Jan 25.

17.

Aberrant promoter methylation and expression of UTF1 during cervical carcinogenesis.

Guenin S, Mouallif M, Deplus R, Lampe X, Krusy N, Calonne E, Delbecque K, Kridelka F, Fuks F, Ennaji MM, Delvenne P.

PLoS One. 2012;7(8):e42704. doi: 10.1371/journal.pone.0042704. Epub 2012 Aug 3.

18.

The histone demethylase Kdm3a is essential to progression through differentiation.

Herzog M, Josseaux E, Dedeurwaerder S, Calonne E, Volkmar M, Fuks F.

Nucleic Acids Res. 2012 Aug;40(15):7219-32. doi: 10.1093/nar/gks399. Epub 2012 May 11.

19.

DNA methylation profiling identifies epigenetic dysregulation in pancreatic islets from type 2 diabetic patients.

Volkmar M, Dedeurwaerder S, Cunha DA, Ndlovu MN, Defrance M, Deplus R, Calonne E, Volkmar U, Igoillo-Esteve M, Naamane N, Del Guerra S, Masini M, Bugliani M, Marchetti P, Cnop M, Eizirik DL, Fuks F.

EMBO J. 2012 Mar 21;31(6):1405-26. doi: 10.1038/emboj.2011.503. Epub 2012 Jan 31.

20.

Evaluation of the Infinium Methylation 450K technology.

Dedeurwaerder S, Defrance M, Calonne E, Denis H, Sotiriou C, Fuks F.

Epigenomics. 2011 Dec;3(6):771-84. doi: 10.2217/epi.11.105.

21.

DNA methylation profiling reveals a predominant immune component in breast cancers.

Dedeurwaerder S, Desmedt C, Calonne E, Singhal SK, Haibe-Kains B, Defrance M, Michiels S, Volkmar M, Deplus R, Luciani J, Lallemand F, Larsimont D, Toussaint J, Haussy S, Rothé F, Rouas G, Metzger O, Majjaj S, Saini K, Putmans P, Hames G, van Baren N, Coulie PG, Piccart M, Sotiriou C, Fuks F.

EMBO Mol Med. 2011 Dec;3(12):726-41. doi: 10.1002/emmm.201100801. Epub 2011 Nov 16.

22.

Largest ever DNA methylation dataset for breast cancer completed.

Dedeurwaerder S, Desmedt C, Calonne E.

Expert Rev Mol Diagn. 2011 Jun;11(5):470.

PMID:
21842555

Supplemental Content

Loading ...
Support Center